13F filer · CIK 1562230 ↗

Capital International Investors

You are looking at Q3 2019. See the latest, Q2 2026 →

Reported value

$261.94B

+4.5% on the quarter before

Positions

402

45 new · 31 sold out

Top 10

26.5%

of the value

Est. gain

−$95.5M

on stocks held all quarter

Est. return

−0.0%

on those stocks since Q2 2019

Filed

Nov 14, 2019

On SEC EDGAR ↗

Positions as of Sep 30, 2019, from Capital International Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 44% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2019. Striped tiles are options.

Microsoft5.3%Meta3.0%Broadcom2.9%Amazon2.8%Intel2.8%
Northrop Grumman Corp2.2%
Unitedhealth Group Inc2.1%
Alphabet2.0%
Comcast Corp Cl A1.8%
Charter Communications Inc Cl A1.7%
Boeing Co1.6%
Enbridge Inc1.6%
Abbott Laboratories1.5%
Chevron Corp1.4%
Visa Inc.1.4%
Chubb Ltd1.3%
Merck And Co Inc1.2%
Jpmorgan Chase And Co1.2%
Coca-Cola Co1.2%
Activision Blizzard Inc1.1%
Cme Group Inc Cl A1.1%
Eli Lilly1.1%
Eog Resources Inc1.1%
Philip Morris International1.0%

Largest buys

Since Q2 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Boeing Co~$1.32BAdded · 1.1% → 1.6%+3,480,868 shares
  2. Pnc Financial Services Group Inc~$894.3MAdded · 0.3% → 0.6%+6,380,354 shares
  3. Netflix~$852.5MAdded · 0.7% → 0.8%+3,185,374 shares
  4. Unitedhealth Group Inc~$676.3MAdded · 2.1% → 2.1%+3,111,955 shares
  5. Northrop Grumman Corp~$671.5MAdded · 1.7% → 2.2%+1,791,683 shares
  6. Abbott Laboratories~$663.3MAdded · 1.3% → 1.5%+7,927,194 shares
  7. Lyondellbasell Industries Nv~$614.6MAdded · 0.1% → 0.4%+6,869,875 shares
  8. Broadcom~$583.4MAdded · 2.9% → 2.9%+2,113,229 shares
  9. First Republic Bank~$581.9MAdded · 0.2% → 0.4%+6,017,418 shares
  10. Charter Communications Inc Cl A~$581.8MAdded · 1.5% → 1.7%+1,411,789 shares

Largest sells

Since Q2 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Wells Fargo And Co~$1.18BCut · 1.1% → 0.7%−23,371,741 shares
  2. Amgen Inc~$768.6MCut · 0.7% → 0.4%−3,972,062 shares
  3. Texas Instruments~$602.2MCut · 0.9% → 0.7%−4,659,368 shares
  4. Abbvie Inc~$504.6MCut · 0.5% → 0.3%−6,663,544 shares
  5. Verizon Communications Inc~$476.1MCut · 0.9% → 0.7%−7,887,411 shares
  6. Occidental Petroleum Corp~$432.1MCut · 0.2% → 0.0%−9,716,532 shares
  7. Royal Dutch Shell Plc B ADR~$406.8MCut · 0.8% → 0.6%−6,792,079 shares
  8. Lowes Companies Inc~$391.3MSold out · 0.2% → 0.0%−3,877,926 shares
  9. Mgm Resorts International~$385.8MSold out · 0.2% → 0.0%−13,502,432 shares
  10. Hormel Foods Corp~$373.2MCut · 0.3% → 0.2%−8,533,926 shares

Holdings

As of Sep 30, 2019. Changes are in shares against Jun 30, 2019, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
MicrosoftCOMMON STOCK · shares +4.4% · price +3.8%5.3%$13.76B+$480.6M
MetaCOMMON STOCK · shares +7.1% · price −7.7%3.0%$7.91B−$618.8M
BroadcomCOMMON STOCK · shares +8.3% · price −4.1%2.9%$7.58B−$298.7M
AmazonCOMMON STOCK · shares +2.6% · price −8.3%2.8%$7.35B−$651.3M
IntelCOMMON STOCK · shares +6.5% · price +7.6%2.8%$7.28B+$485.4M
Northrop Grumman CorpCOMMON STOCK · shares +13% · price +16.0%2.2%$5.74B+$699.5M
Unitedhealth Group IncCOMMON STOCK · shares +14% · price −10.9%2.1%$5.38B−$577.8M
AlphabetCOMMON STOCK · shares −1.3% · price +12.8%2.0%$5.26B+$595.8M
Comcast Corp Cl ACOMMON STOCK · shares +8.1% · price +6.6%1.8%$4.62B+$265.3M
Charter Communications Inc Cl ACOMMON STOCK · shares +15% · price +4.3%1.7%$4.46B+$159.6M
Boeing CoCOMMON STOCK · shares +45% · price +4.5%1.6%$4.28B+$127.8M
Enbridge IncCOMMON STOCK · shares −0.7% · price −2.8%1.6%$4.09B−$117.8M
Abbott LaboratoriesCOMMON STOCK · shares +21% · price −0.5%1.5%$3.85B−$16.4M
Chevron CorpCOMMON STOCK · shares +10% · price −4.7%1.4%$3.69B−$164.7M
Visa Inc.COMMON STOCK · shares +9.5% · price −0.9%1.4%$3.65B−$29.9M
Chubb LtdCOMMON STOCK · shares +15% · price +9.6%1.3%$3.36B+$257.4M
Merck And Co IncCOMMON STOCK · shares +4.5% · price +0.4%1.2%$3.25B+$12.2M
Jpmorgan Chase And CoCOMMON STOCK · shares +14% · price +5.3%1.2%$3.10B+$136.4M
Coca-Cola CoCOMMON STOCK · shares −8.4% · price +6.9%1.2%$3.08B+$199.2M
Activision Blizzard IncCOMMON STOCK · shares +23% · price +12.1%1.1%$2.90B+$254.5M
Cme Group Inc Cl ACOMMON STOCK · shares +0.1% · price +8.9%1.1%$2.85B+$231.8M
Eli LillyCOMMON STOCK · shares +26% · price +0.9%1.1%$2.81B+$20.7M
Eog Resources IncCOMMON STOCK · shares +9.0% · price −20.3%1.1%$2.79B−$652.5M
Philip Morris InternationalCOMMON STOCK · shares +5.9% · price −3.3%1.0%$2.72B−$87.9M
Transdigm Group IncCOMMON STOCK · shares +0.9% · price +7.6%1.0%$2.70B+$189.7M
Total · 402 positions100%$261.94B−$95.5M
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q2 2019 to Q3 2019: 357 stocks held throughout, down $95.5M (−0.0%).

  1. Northrop Grumman Corp+$699.5M+16%
  2. Alphabet+$595.8M+13%
  3. Intel+$485.4M+8%
  4. Microsoft+$480.6M+4%
  5. Comcast Corp Cl A+$265.3M+7%
  6. Netflix−$468.5M−27%
  7. Unitedhealth Group Inc−$577.8M−11%
  8. Meta−$618.8M−8%
  9. Amazon−$651.3M−8%
  10. Eog Resources Inc−$652.5M−20%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$700.00B$350.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$483.61B+13%SEC ↗
Q1 2026$426.52B−33%SEC ↗
Q4 2025$637.97B+3%SEC ↗
Q3 2025$619.40B+7%SEC ↗
Q2 2025$580.56B+14%SEC ↗
Q1 2025$508.52B−4%SEC ↗
Q4 2024$532.30B+2%SEC ↗
Q3 2024$520.97B+7%SEC ↗
Q2 2024$485.73B−2%SEC ↗
Q1 2024$493.90B+11%SEC ↗
Q4 2023$446.09B+13%SEC ↗
Q3 2023$394.11B−5%SEC ↗
Q2 2023$414.45B+7%SEC ↗
Q1 2023$388.71B+4%SEC ↗
Q4 2022$372.54B+9%SEC ↗
Q3 2022$342.83B−7%SEC ↗
Q2 2022$367.64B−16%SEC ↗
Q1 2022$438.61B−7%SEC ↗
Q4 2021$473.03B+8%SEC ↗
Q3 2021$437.44B−0%SEC ↗
Q2 2021$437.89B+11%SEC ↗
Q1 2021$395.24B+8%SEC ↗
Q4 2020$366.38B+13%SEC ↗
Q3 2020$323.46B+6%SEC ↗
Q2 2020$305.21B+25%SEC ↗
Q1 2020$244.50B−17%SEC ↗
Q4 2019$294.42B+12%SEC ↗
Q3 2019$261.94B+5%SEC ↗
Q2 2019$250.64B+8%SEC ↗
Q1 2019$232.80B+16%SEC ↗
Q4 2018$200.60B−8%SEC ↗
Q3 2018$218.36B+147%SEC ↗
Q2 2018$88.55B+2%SEC ↗
Q1 2018$86.51B−2%SEC ↗
Q4 2017$88.52B+6%SEC ↗
Q3 2017$83.48B+11%SEC ↗
Q2 2017$74.88B+2%SEC ↗
Q1 2017$73.61B+6%SEC ↗
Q4 2016$69.28B+0%SEC ↗
Q3 2016$68.95B+1%SEC ↗
Q2 2016$68.21B+5%SEC ↗
Q1 2016$65.22BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.